Latest receivables for SVRA: $1.1M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Savara (SVRA) currently reports a receivables of $1.1M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Savara's receivables history and peer comparisons.
Savara's receivables changed from $0 to $1.1M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Savara reported $1.1M in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $1.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Savara, and consider following SVRA for alerts when major investors trade the stock.
Savara is classified in the Healthcare sector. On receivables, it currently shows $1.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SVRA with unrelated industries.